Feautured Physicians
Physician and Healthcare Worker Interviews

Insights from worlwide CML physicians help
patients understand their disease and the
treatments currently available to treat and
control the disease.  Moreover, the prognosis of
CML needs to be explained in layman terms to
the patients by physicians.

Most CML patients are on long-term drug
therapies and need to adjust to living with CML.  
Diagnosis time is a traumatic time for CML
patients and even if doing well, some patients
have to deal with depression.

Additionally, access to CML drugs can be
confusing with the new Medicare program in the
USA.

On this page, I have included interviews of
several CML physicians and healthcare
professionals who gave of their time to answer
questions from CML patients.  Also included is a
Links section which have URLs linking to
physician webcasts hosted by the Leukemia and
Lymphoma Society of America.

  • Dr. Franck Nicolini is a leading CML Expert
    and hematologist from University Hospital
    Edouard Herriot at Lyons, France.  He also
    conducts new CML drug trials of Dasatinib,
    HHT and AMN107.

  • Dr. Goh Yeow Tee is a leading CML expert
    and hematologist from Singapore leading
    new CML drug trials of Dasatinib, Nilotinib,
    MK-0457 and other drugs.  He is also a
    leading transplant specialist from Asia.
  • Dr. Mark Juckett is a hematologist from the
    University of Wisconsin at Madison, a doctor
    who can explain CML to the patient
    confidently and reassuringly.
  • Dr. Kim is a leading CML expert and
    hematologist from South Korea, leading new
    CML drug trials of Dasatinib, Nilotinib, MK-
    0457 and other drugs.  He kindly shares the
    results of the new CML drugs.
  • Dr. Mark Heiland is a psychologist from the
    University of Wisconsin at Madison and
    gives his insight on how patients can deal
    with the disease on an emotional level after
    diagnosis.
  • Ms. Joana Ramos is a cancer advocate,
    consultant and oncology social worker,
    herself an NHL and transplant survivor, who
    methodically explains Medicare Part D and
    how it covers prescription drugs in the USA.